Jayesh M D Patel: Platelet-Rich Plasma and Ovarian Reactivation in Postmenopausal Women
Jayesh M D Patel, APSF Social Ambassador, Specialist Anaesthetist at Jayesh Patel Anaesthetic Services Limited, shared Ratanak Roth Oeurn – Kent‘s post on LinkedIn, adding:
“In the news:
Endocrinologists have achieved the complete reversal of menopause in post-menopausal women, restoring fully functional ovarian cycles, natural hormone profiles, and confirmed ovulation in women aged 45 to 62.
In a trial of 290 post-menopausal women, a 97% success rate was recorded in restoring measurable follicular activity within 12 weeks, with 34 participants achieving natural pregnancies within 6 months — the oldest being 59 years old.
The treatment involves injecting platelet-rich plasma (PRP) combined with a proprietary mitochondrial activator directly into ovarian tissue, reawakening dormant primordial follicles that had ceased activity.
This triggers the hypothalamic-pituitary-ovarian axis back into full hormonal rhythm — restoring estradiol, progesterone, FSH, and LH to levels comparable to a 28-year-old woman.
Beyond fertility, patients reported elimination of hot flashes, restoration of bone density, and dramatic improvements in cognitive clarity.
Menopause has just been reclassified from an inevitability to a reversible biological state.
Take note TeWhatuOra.
Are you really a centre of excellence?
If you don’t measure you cant improve!
How can you improve if you dont know!
Respect our patients’ most important organ!
Monitor the target organ!
Ditch surrogate cardiovascular parameters in guiding anaesthesia!!!
Practice scientifically.
Practice objectively administer analgesia scientifically, use advanced nociception monitoring.
Superior to any anaesthesiologist!!!”
Title: Persistent Opioid Use After Hospital Admission From Surgery in New Zealand: A Population-Based Study
Authors: Jiayi Gong, Peter Jones, Chris Frampton, Kebede Beyene, Amy Hai Yan Chan
Read the Full Article on Anesthesia and Analgesia

Title: Outcomes Related to New Persistent Opioid Use After Surgery or Trauma: A Population-based Cohort Study
Authors: Jiayi Gong, Peter Jones, Kebede Beyene, Chris Frampton, Amy Hai Yan Chan
Read the Full Article on Annals of Surgery

Ratanak Roth Oeurn – Kent, Founder, Chairman, CEO at WORLD NEWS 24/7, shared a post on LinkedIn:
“In the news:
A biological miracle is happening in elite longevity and reproductive clinics, where endocrinologists have achieved what biology previously declared impossible — the complete reversal of menopause in post-menopausal women, restoring fully functional ovarian cycles, natural hormone profiles, and confirmed ovulation in women aged 45 to 62.
In a trial of 290 post-menopausal women, a 97% success rate was recorded in restoring measurable follicular activity within 12 weeks, with 34 participants achieving natural pregnancies within 6 months — the oldest being 59 years old.
The treatment involves injecting platelet-rich plasma (PRP) combined with a proprietary mitochondrial activator directly into ovarian tissue, reawakening dormant primordial follicles that had ceased activity.
This triggers the hypothalamic-pituitary-ovarian axis back into full hormonal rhythm — restoring estradiol, progesterone, FSH, and LH to levels comparable to a 28-year-old woman.
Beyond fertility, patients reported elimination of hot flashes, restoration of bone density, and dramatic improvements in cognitive clarity.
Menopause has just been reclassified from an inevitability to a reversible biological state.”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 14:30Bharat Moyal: The New KDIGO 2026 Approach to Anemia in CKD
-
Aug 11, 2026, 14:16Rayan Ahmed: Master Blood Films and Pathology Online
-
Aug 11, 2026, 13:53Steven Lubega: Why Are Healthy Newborns Born Poorly Equipped To Stop Bleeding?
-
Aug 11, 2026, 13:47Why Stroke Risk Changes During Pregnancy – International Journal of Stroke
-
Aug 11, 2026, 13:43Moyahabo Julius Rampya: Shaping the Future of Stroke Care in Africa
-
Aug 11, 2026, 13:34Brett Hoover: Plaque Burden May Be Key to Predicting MACE Risk
-
Aug 11, 2026, 11:47Rucha Patil: Strengthening Evidence-Based Haemophilia Care Across India
-
Aug 11, 2026, 11:38Maria Hadjidemetriou: The Patient Perspective in Thalassemia Care
-
Aug 11, 2026, 11:04Wolfgang Miesbach: The Critical Need for Tailored Dosing in VWD